Clinical Report: Definitions and Diagnostic Criteria for Residual Stone Fragments

Overview

Residual stone fragments (RSFs) after urolithiasis treatments such as ESWL, PCNL, and RIRS remain a clinical challenge due to their association with adverse outcomes. This systematic review highlights the variability in RSF definitions, diagnostic modalities, and management strategies, emphasizing the need for standardized criteria and risk stratification.

Background

RSFs following shock wave lithotripsy and endourological procedures can lead to stone regrowth, infection, obstruction, and re-intervention, impacting patient outcomes and healthcare resources. Imaging modalities including NCCT, ultrasonography, and radiographs are used to detect RSFs, with NCCT considered the gold standard for sensitivity. Despite advances in surgical techniques, there is no consensus on the clinical significance of RSFs or standardized definitions, complicating treatment goals and follow-up protocols. This review systematically evaluates current literature to propose unified definitions, diagnostic approaches, and risk stratification models for RSFs.

Data Highlights

A total of 3881 records were initially identified, with 29 studies included after screening and eligibility assessment. These studies were categorized by treatment type: ESWL (n=12), RIRS (n=7), and PCNL (n=10). Nine studies defined RSFs as fragments smaller than 4 mm. Risk of bias was assessed using the QUADAS-2 tool, and statistical analyses including meta-analysis and correlation tests were performed to evaluate RSF size, spontaneous passage, and intervention rates.

Key Findings

• RSFs are variably defined across studies, with many considering fragments <4 mm as clinically insignificant.
• NCCT is the preferred imaging modality due to its superior sensitivity, despite concerns about cost and radiation exposure.
• There is no standardized consensus on the clinical significance of RSFs, with size, number, location, and composition influencing risk assessments.
• Follow-up protocols and imaging modalities vary widely, complicating management and outcome comparisons.
• Risk stratification models are proposed to classify patients based on RSF characteristics to guide management decisions.
• Most studies included were retrospective with variable quality, highlighting the need for prospective standardized research.

Clinical Implications

Clinicians should recognize the heterogeneity in RSF definitions and adopt standardized imaging protocols, preferably using NCCT, to accurately detect residual fragments. Understanding the size and characteristics of RSFs can guide risk stratification and individualized patient management to reduce complications and the need for re-intervention. Consensus on definitions and follow-up strategies is essential to improve clinical outcomes and research comparability.

Conclusion

This systematic review underscores the necessity for standardized definitions and diagnostic criteria for RSFs in urolithiasis management. Implementing unified approaches and risk stratification models will enhance clinical decision-making and optimize patient outcomes.

References

1. Systematic Review 2024 -- Definitions and Diagnostic Criteria for Residual Stone Fragments